Table 2. ADMET properties of Quercetin and Remdesivir.
| Property | Model Name | Quercetin | Remdesivir |
| Water solubility | -2.925 | -3.07 | |
| Caco2 permeability | -0.0229 | 0.635 | |
| Absorption | Intestinal absorption (human) | 77.2 | 71.109 |
| P-glycoprotein substrate | YES | YES | |
| VDss (human) | 1.559 | 0.307 | |
| Fraction unbound (human) | 0.206 | 0.005 | |
| Distribution | BBB permeability | -1.098 | -2.056 |
| CNS permeability | -3.065 | -4.675 | |
| Metabolism | CYP2D6 substrate | NO | NO |
| CYP3A4 substrate | NO | YES | |
| CYP2D6 inhibitior | NO | NO | |
| CYP3A4 inhibitior | NO | NO | |
| Excretion | Total Clearance | -0.407 | 0.198 |
| Renal OCT2 substrate | NO | NO | |
| hERG I inhibitor | NO | NO | |
| hERG II inhibitor | NO | YES | |
| Oral Rat Acute Toxicity (LD50) | 2.47 | 2.043 | |
| Hepatotoxicity | NO | YES |